Results 31 to 40 of about 13,607 (200)

Chronic Kidney Disease Stage Is a Modulator on the Association between High-Sensitivity C-Reactive Protein and Coronary Vasospastic Angina

open access: yesThe Scientific World Journal, 2014
The prevalence of coronary vasospasm and also the factors associated with coronary vasospasm in CKD is still unclear. In this cross-sectional study of 859 consecutive CKD patients with angina pectoris received coronary catheterization, we evaluated the ...
Heng-Jung Hsu   +11 more
doaj   +1 more source

Severe familial coronary artery spasm in 2 siblings: About 2 cases

open access: yesRadiology Case Reports, 2023
Vasospastic angina is the spasm of coronary arteries causing transient myocardial ischemia. VSA is commonly managed with antispasmodic medications including calcium-channel blockers and nitrates.
Oualid Kerrouani, MD   +8 more
doaj   +1 more source

Successful brachytherapy of coronary vasospasm [PDF]

open access: yesHeart, 2003
Brachytherapy is a proposed treatment for in-stent restenosis and is the subject of several clinical trials and debates. The standard treatment of patients with variant angina is to eliminate vasoconstrictive factors and to administer vasodilating drugs. This is the first description of successful brachytherapy for coronary spasm.
T, Chatterjee   +3 more
openaire   +2 more sources

Coronary vasospasm testing: escape from the cath lab! [PDF]

open access: yesExploration of Cardiology
Coronary vasospasm stands as a widely acknowledged and frequent culprit behind chest pain, acute coronary syndrome, and sudden cardiac death, yet it remains a challenging diagnosis.
Ana Djordjevic Dikic   +3 more
doaj   +1 more source

Coronary Microvascular Spasm: Clinical Presentation and Diagnosis

open access: yesEuropean Cardiology Review, 2023
Professor Maseri pioneered the research and treatment of coronary vasomotion abnormalities represented by coronary vasospasm and coronary microvascular dysfunction (CMD).
Shigeo Godo   +4 more
doaj   +1 more source

Cardiac arrest due to coronary vasospasm after sugammadex administration -a case report- [PDF]

open access: yesKorean Journal of Anesthesiology, 2023
Background Sugammadex is a widely used medication for the reversal of aminosteroid neuromuscular blockades. Although sugammadex is generally regarded to be safe, concerns about the risk of serious complications have emerged.
Ki Yung Boo   +4 more
doaj   +1 more source

Myocardial infarction with non-obstructive coronary arteries (MINOCA)

open access: yesFrontiers in Cardiovascular Medicine, 2022
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is evident in up to 15% of all acute myocardial infarctions (AMI) and disproportionally affects females. Despite younger age, female predominance, and fewer cardiovascular risk factors,
Mehmet Yildiz   +6 more
doaj   +1 more source

Hyperthyroidism Presenting with Coronary Vasospasm

open access: yesJournal of the College of Physicians and Surgeons Pakistan, 2022
Hyperthyroidism is associated with a number of heart diseases, and it may aggravate previous cardiac problems or cause new ones, such as hyperthyroid cardiopathy. Cases of hyperthyroidism presenting with coronary vasospasm are rarely reported. Herein, we present a case of a 54-year male patient with recurrent left chest pain for 2 months.
Cong-Qing, Miao   +4 more
openaire   +2 more sources

Acute coronary syndrome secondary to allergic coronary vasospasm (Kounis Syndrome): a case series, follow-up and literature review

open access: yesBMC Cardiovascular Disorders, 2018
Background Kounis syndrome (KS) is the concurrence of acute coronary syndrome associated with mast-cell and platelet activation in the setting of hypersensitivity and allergic or anaphylactic insults.
Jing Li   +4 more
doaj   +1 more source

Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions

open access: yesInterventional Cardiology: Reviews, Research, Resources, 2019
Cardiovascular disease and cancer are leading contributors to the global disease burden. As a result of cancer therapy-related cardiotoxicities, cardiovascular disease results in significant morbidity and mortality in cancer survivors and patients with ...
Jun Hua Chong, Arjun K Ghosh
doaj   +1 more source

Home - About - Disclaimer - Privacy